Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury (ABELADRUG200)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2010 by Abela Pharmaceuticals, Inc..
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Ohio State University
University of California, Irvine
Dr. Mahajan's Hospital & Industrial Trauma Centre
Information provided by:
Abela Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00810940
First received: December 16, 2008
Last updated: December 6, 2010
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)